ZFP57 Gene Maturity-onset diabetes of the young ZFP57 related Genetic Test
Test Name: ZFP57 Gene Maturity-onset diabetes of the young ZFP57 related Genetic Test
Components: NGS Technology
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Test Type: Metabolic Disorders
Doctor: General Physician
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for ZFP57 Gene Maturity-onset diabetes of the young, ZFP57 related NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Maturity-onset diabetes of the young, ZFP57 related.
Test Details:
The ZFP57 gene is involved in the development and function of beta cells in the pancreas, which are responsible for producing insulin. Mutations in this gene have been associated with a rare form of diabetes known as maturity-onset diabetes of the young (MODY), specifically MODY type 1.
Maturity-onset diabetes of the young is a monogenic form of diabetes, meaning it is caused by a mutation in a single gene rather than a combination of genetic and environmental factors. MODY is typically diagnosed in young individuals, often before the age of 25, and is characterized by mild hyperglycemia (high blood sugar levels) that is often controlled without the need for insulin treatment.
A ZFP57-related next-generation sequencing (NGS) genetic test is a diagnostic tool used to identify mutations in the ZFP57 gene. This test involves analyzing the individual’s DNA to detect any alterations or variants in the gene sequence that may be associated with MODY type 1.
By identifying mutations in the ZFP57 gene, healthcare professionals can confirm a diagnosis of MODY type 1 and provide appropriate management and treatment strategies. This may include lifestyle modifications, oral medications, or insulin therapy, depending on the severity of the condition.
It is important to note that MODY is a rare form of diabetes, and not all cases are caused by mutations in the ZFP57 gene. There are several other genes associated with different types of MODY, and genetic testing may be used to identify mutations in these genes as well.
Genetic testing can help in accurate diagnosis, genetic counseling, and personalized treatment for individuals with MODY.
| Test Name | ZFP57 Gene Maturity-onset diabetes of the young ZFP57 related Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Metabolic Disorders |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for ZFP57 Gene Maturity-onset diabetes of the young, ZFP57 related NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Maturity-onset diabetes of the young, ZFP57 related |
| Test Details | The ZFP57 gene is involved in the development and function of beta cells in the pancreas, which are responsible for producing insulin. Mutations in this gene have been associated with a rare form of diabetes known as maturity-onset diabetes of the young (MODY), specifically MODY type 1. Maturity-onset diabetes of the young is a monogenic form of diabetes, meaning it is caused by a mutation in a single gene rather than a combination of genetic and environmental factors. MODY is typically diagnosed in young individuals, often before the age of 25, and is characterized by mild hyperglycemia (high blood sugar levels) that is often controlled without the need for insulin treatment. A ZFP57-related next-generation sequencing (NGS) genetic test is a diagnostic tool used to identify mutations in the ZFP57 gene. This test involves analyzing the individual’s DNA to detect any alterations or variants in the gene sequence that may be associated with MODY type 1. By identifying mutations in the ZFP57 gene, healthcare professionals can confirm a diagnosis of MODY type 1 and provide appropriate management and treatment strategies. This may include lifestyle modifications, oral medications, or insulin therapy, depending on the severity of the condition. It is important to note that MODY is a rare form of diabetes, and not all cases are caused by mutations in the ZFP57 gene. There are several other genes associated with different types of MODY, and genetic testing may be used to identify mutations in these genes as well. Genetic testing can help in accurate diagnosis, genetic counseling, and personalized treatment for individuals with MODY. |
